BR9909044A - Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante - Google Patents
Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinanteInfo
- Publication number
- BR9909044A BR9909044A BR9909044-9A BR9909044A BR9909044A BR 9909044 A BR9909044 A BR 9909044A BR 9909044 A BR9909044 A BR 9909044A BR 9909044 A BR9909044 A BR 9909044A
- Authority
- BR
- Brazil
- Prior art keywords
- nucleic acid
- acid transfer
- transfer vector
- cells
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"VETOR DE TRANSFERêNCIA DE áCIDOS NUCLEICOS, COMPOSIçãO, UTILIZAçãO DE UM VETOR DE TRANSFERêNCIA DE áCIDOS NUCLEICOS, PROCESSOS DE TRANSFECçãO DE áCIDOS NUCLEICOS NAS CéLULAS, E DE TRATAMENTO DE DOENçAS, E, CéLULA RECOMBINANTE". A presente invenção refere-se a novos vetores e sua utilização para a transferência de ácidos nucleicos. Mais particularmente, a invenção refere-se a novos vetores capazes de dirigir os ácidos nucleicos para as células ou os compartimentos celulares específicos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9803573A FR2776669B1 (fr) | 1998-03-24 | 1998-03-24 | Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations |
US8584898P | 1998-05-18 | 1998-05-18 | |
PCT/FR1999/000643 WO1999049067A1 (fr) | 1998-03-24 | 1999-03-19 | Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9909044A true BR9909044A (pt) | 2000-12-05 |
Family
ID=26234216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9909044-9A BR9909044A (pt) | 1998-03-24 | 1999-03-19 | Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1066396A1 (pt) |
JP (1) | JP2002507429A (pt) |
KR (1) | KR20010074456A (pt) |
CN (1) | CN1292827A (pt) |
AU (1) | AU758406B2 (pt) |
BR (1) | BR9909044A (pt) |
CA (1) | CA2323831A1 (pt) |
HU (1) | HUP0102413A3 (pt) |
IL (1) | IL138624A0 (pt) |
NO (1) | NO20004648D0 (pt) |
PL (1) | PL342944A1 (pt) |
WO (1) | WO1999049067A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2298239T3 (es) * | 2000-05-26 | 2008-05-16 | Centelion | Purificacion de una formacion de triple helice con oligonucleotido inmovilizado. |
FR2871465B1 (fr) * | 2004-06-15 | 2006-09-08 | Centre Nat Rech Scient Cnrse | Collections de composes tracables et leurs utilisations |
US7943589B2 (en) | 2005-06-03 | 2011-05-17 | President And Fellows Of Harvard College | siRNA microbicides for preventing and treating diseases |
US7795380B2 (en) | 2006-06-02 | 2010-09-14 | University Of Iowa Research Foundation | Compositions and methods for nucleic acid delivery |
EP3427054A4 (en) * | 2016-03-07 | 2019-12-04 | Quidel Cardiovascular Inc. | IMMUNOASSAY CHECKS AND USE THEREOF |
RU2731513C2 (ru) * | 2018-12-21 | 2020-09-03 | Селл энд Джин Терапи Лтд | Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2028792A (en) * | 1991-05-17 | 1992-12-30 | Uab Research Foundation | Sequence specific dna binding drugs |
US5670347A (en) * | 1994-05-11 | 1997-09-23 | Amba Biosciences Llc | Peptide-mediated gene transfer |
FR2731014B1 (fr) * | 1995-02-23 | 1997-03-28 | Rhone Poulenc Rorer Sa | Molecules d'adn, preparation et utilisation en therapie genique |
-
1999
- 1999-03-19 BR BR9909044-9A patent/BR9909044A/pt not_active IP Right Cessation
- 1999-03-19 IL IL13862499A patent/IL138624A0/xx unknown
- 1999-03-19 EP EP99910417A patent/EP1066396A1/fr not_active Withdrawn
- 1999-03-19 KR KR1020007010485A patent/KR20010074456A/ko not_active Application Discontinuation
- 1999-03-19 JP JP2000538027A patent/JP2002507429A/ja not_active Withdrawn
- 1999-03-19 CA CA002323831A patent/CA2323831A1/fr not_active Abandoned
- 1999-03-19 PL PL99342944A patent/PL342944A1/xx not_active Application Discontinuation
- 1999-03-19 WO PCT/FR1999/000643 patent/WO1999049067A1/fr not_active Application Discontinuation
- 1999-03-19 HU HU0102413A patent/HUP0102413A3/hu unknown
- 1999-03-19 CN CN998039314A patent/CN1292827A/zh active Pending
-
2000
- 2000-05-12 AU AU34062/00A patent/AU758406B2/en not_active Ceased
- 2000-09-18 NO NO20004648A patent/NO20004648D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU758406B2 (en) | 2003-03-20 |
EP1066396A1 (fr) | 2001-01-10 |
KR20010074456A (ko) | 2001-08-04 |
NO20004648L (no) | 2000-09-18 |
CN1292827A (zh) | 2001-04-25 |
JP2002507429A (ja) | 2002-03-12 |
IL138624A0 (en) | 2001-10-31 |
NO20004648D0 (no) | 2000-09-18 |
HUP0102413A3 (en) | 2003-09-29 |
CA2323831A1 (fr) | 1999-09-30 |
AU3406200A (en) | 2000-12-14 |
WO1999049067A1 (fr) | 1999-09-30 |
HUP0102413A1 (hu) | 2001-10-28 |
PL342944A1 (en) | 2001-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR006188A1 (es) | "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion". | |
ES2147553T3 (es) | Vectores virales recombinantes para la expresion en unas celulas musculares. | |
BG102554A (en) | Vectors and methods for gene transfer into cells | |
BR9910251A (pt) | Estimulação hematopoiética | |
BR9810369A (pt) | Processo de transferência de ácido nucleico para o interior de um ou mais músculos estriados, in vivo, composição, ácido mucleico e campo elétrico, e, produto de combinação | |
BR0316234A (pt) | Hidroxiindóis, seu uso como inibidores de fosfodiesterase 4 e processos para a preparação dos mesmos | |
BR0007663A (pt) | Derivados de acila para uso no tratamento de doenças relacionadas com o vla-4 | |
MX9800719A (es) | Proteinas de transporte y sus usos. | |
BR0010496A (pt) | Regulação da expressão genica viral | |
DE50013093D1 (de) | Sequenz-spezifische dna-rekombination in eukaryotischen zellen | |
WO1999033980A3 (en) | Members of tnf and tnfr families | |
FR2470794A1 (fr) | Nouvelles microparticules, leur preparation et leurs applications en biologie, notamment a la culture de cellules diploides humaines | |
CY1108603T1 (el) | Συστηματα πρωτεϊνων μεταφορας λιπιδιων και η καλλυντικη δερματολογικη εφαρμογη τους | |
BR9809506A (pt) | Composto, composição, utilização de um composto, e, processos para preparação de um composto e para transferência de ácidos nucleicos para o interior das células | |
ATE215099T1 (de) | Kationische polymere, diese kationische polymere enthaltende komplexe und wenigstens eine negative ladung enthaltende therapeutisch wirksame mittel, insbesondere nukleinsäuren und ihre verwendung in gentherapie | |
TR199801840A2 (xx) | Yeni imidazolidin t�revleri ve bunlar� i�eren farmakolojik preparatlar. | |
TR199802648A2 (xx) | Gen tedavisi i�in n�klein asit yap�lar�. | |
TR200002248T2 (tr) | Yeni dihidroksiheksanoik asit türevleri | |
BR9909044A (pt) | Vetor de tranferência de ácidos nucleicos, composição, utilização de um vetor de tranferência de ácidos nucleicos, processos de transfecção de ácidos nucleicos nas células, e de tratamento de doenças, e, célula recombinante | |
ATE386130T1 (de) | Adenovirale vektoren für die gentherapie | |
DE60037978D1 (de) | Interferon ähnliche moleküle, und deren verwendungen | |
HUP9800613A2 (hu) | Humán Fas-antigén elleni humanizált antitest | |
BR9507473A (pt) | Sequéncia de dna isolada vetor célula hospedeira processo para produzir uma proteina gp350 homogénea proteína gp350 homogénea composição farmacéutica e uso na proteina gp350 homogénea | |
BR9908443A (pt) | Linhagens de células de medula espinhal humana e métodos para uso das mesmas | |
CA2385872A1 (en) | Gene transfer in human lymphocytes using retroviral scfv cell targeting |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008. |